Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: A single-center experience

被引:129
作者
De Soyza, Anthony [1 ]
Meachery, Gerard [2 ]
Hester, Katy L. M. [2 ]
Nicholson, Audrey [3 ]
Parry, Gareth [2 ]
Tocewicz, Krzysztof [2 ]
Pillay, Thasee [2 ]
Clark, Stephen [2 ]
Lordan, James L. [2 ]
Schueler, Stephan [2 ]
Fisher, Andrew J. [1 ,2 ]
Dark, John H. [2 ]
Gould, F. Kate [2 ,3 ]
Corris, Paul A. [1 ,2 ]
机构
[1] Newcastle Univ, Transplantat & Immunol Grp, Inst Cellular Med, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
[2] Freeman Rd Hosp, Dept Cardiopulm Transplantat, Newcastle Upon Tyne, Tyne & Wear, England
[3] Freeman Rd Hosp, Dept Med Microbiol, Newcastle Upon Tyne, Tyne & Wear, England
关键词
cystic fibrosis; Burkholderia cepacta complex; genomovar; lung transplantation survival; PSEUDOMONAS-CEPACIA; ANTIBIOTIC SUSCEPTIBILITY; GENOMOVAR-III; SURVIVAL; AERUGINOSA; DIAGNOSIS; OUTCOMES; STRAINS; UPDATE; IMPACT;
D O I
10.1016/j.healun.2010.06.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Pre-operative infection with organisms from the Burkholderia cepacia complex (BCC) particularly B cenocepacia has been linked with a poorer prognosis after transplantation compared to patients with cystic fibrosis (CF) without this infection Therefore, many transplant centers do not list these patients for transplantation METHODS We report the early and long-term results of a cohort of lung transplant recipients with CF and pre-operative BCC infection Patients with pre-transplantation BCC infection were identified by case-note review BCC species status was assigned by polymerase chain reaction (PCR)-based techniques Survival rates were compared to recipients with CF without BCC infection Survival rates in BCC subgroups were also compared and then further analyzed pre and post-2001 when a new immunosuppressive and antibiotic regime was introduced for such patients RESULTS Two hundred sixteen patients with CF underwent lung transplantation and 22 had confirmed pre operative BCC infection with 12 of these being B cenocepacia Nine B cenocepacia infected recipients died within the first year, and in 8 BCC sepsis was considered to be the cause of death Despite Instituting a tailored pen operative immunosuppressive and microbiologic care approach for such patients post-transplantation BCC septic deaths occurred frequently in those with pre-transplantation B cenocepacia infection In contrast, recipients infected with other BCC species had significantly better outcomes with post transplantation survival comparable to other recipients with CF CONCLUSIONS Mortality in patients with B cenocepacia infection was unacceptably high and has led to our center no longer accepting patients with this condition onto the lung transplant waiting list Long-term survival in the non B cenocepacia BCC group was excellent, without high rates of acute rejection or bronchrolitis obliterans syndrome (BOS) longer term and these patients continue to be considered for lung transplantation J Heart Lung Transplant 2010 29 1395-1404 (C) 2010 International Society for Heart and Lung Transplantation All rights reserved
引用
收藏
页码:1395 / 1404
页数:10
相关论文
共 40 条
[11]   Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis [J].
Chen, JS ;
Witzmann, KA ;
Spilker, T ;
Fink, RJ ;
LiPuma, JJ .
JOURNAL OF PEDIATRICS, 2001, 139 (05) :643-649
[12]   Twenty-year experience of lung transplantation at a single center: Influence of recipient diagnosis on long-term survival [J].
de Perrot, M ;
Chaparro, C ;
McRae, K ;
Waddell, TK ;
Hadjiliadis, D ;
Singer, LG ;
Pierre, AF ;
Hutcheon, M ;
Keshavjee, S .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (05) :1493-1501
[13]   Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation [J].
De Soyza, A ;
Morris, K ;
McDowell, A ;
Doherty, C ;
Archer, L ;
Perry, J ;
Govan, JRW ;
Corris, PA ;
Gould, K .
THORAX, 2004, 59 (06) :526-528
[14]   Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis [J].
De Soyza, A ;
McDowell, A ;
Archer, L ;
Dark, JH ;
Elborn, SJ ;
Mahenthiralingam, E ;
Gould, K ;
Corris, PA .
LANCET, 2001, 358 (9295) :1780-1781
[15]   POSTTRANSPLANTATION SURVIVAL OF CYSTIC-FIBROSIS PATIENTS INFECTED WITH PSEUDOMONAS-CEPACIA [J].
EGAN, JJ ;
MCNEIL, K ;
BOOKLESS, B ;
GOULD, K ;
CORRIS, P ;
HIGENBOTTAM, T ;
WEBB, AK ;
WOODCOCK, AA .
LANCET, 1994, 344 (8921) :552-553
[16]   Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria [J].
Estenne, M ;
Maurer, JR ;
Boehler, A ;
Egan, JJ ;
Frost, A ;
Hertz, M ;
Mallory, GB ;
Snell, GI ;
Yousem, S .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (03) :297-310
[17]   Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing [J].
Foweraker, JE ;
Laughton, CR ;
Brown, DFJ ;
Bilton, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (06) :921-927
[18]   Comparison of Methods To Test Antibiotic Combinations against Heterogeneous Populations of Multiresistant Pseudomonas aeruginosa from Patients with Acute Infective Exacerbations in Cystic Fibrosis [J].
Foweraker, Juliet E. ;
Laughton, Christian R. ;
Brown, Derek F. ;
Bilton, Diana .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (11) :4809-4815
[19]   Evolving epidemiology of Pseudomonas aerugincisa and the Burkholderia cepacia complex in cystic fibrosis lung infection [J].
Govan, John R. W. ;
Brown, Alan R. ;
Jones, Andrew M. .
FUTURE MICROBIOLOGY, 2007, 2 (02) :153-164
[20]   EVIDENCE FOR TRANSMISSION OF PSEUDOMONAS-CEPACIA BY SOCIAL CONTACT IN CYSTIC-FIBROSIS [J].
GOVAN, JRW ;
BROWN, PH ;
MADDISON, J ;
DOHERTY, CJ ;
NELSON, JW ;
DODD, M ;
GREENING, AP ;
WEBB, AK .
LANCET, 1993, 342 (8862) :15-19